Week of March 19, 2024 | Vol. 13, Issue 12

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines



Quick Links

Who We Are

Investment Banking

Strategic Capital

Research


Contact Information

Xan Smith

Managing Director,

Business Development and Sponsor Coverage

xsmith@bourne-partners.com


Jeremy C. Johnson

Senior Managing Director, Head of Investment Banking

jjohnson@bourne-partners.com

Industry Snapshot

Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.

Upcoming Events

Events Hosted or Attended by Bourne Partners

dcat-week-2023 image
CHPA-logo-new image
ACGGlobal_wAssociationForCorporateGrowth_RGB_1 image
cphi-logo-rgb-na-colour image
MWlogo image
ACGNewYork image

DCAT Week 2024

March 18-21, 2024 - New York, NY

CHPA 2024

March 18-20, 2024 - Amelia Island, FL

ACG DealMAX 2024

April 29-May 1, 2024 - Las Vegas, NV

CHPI North America 2024

May 7-9, 2024 - Philadelphia, PA

McGuireWoods 20th Annual Healthcare Private Equity and Finance Conference

May 8-9, 2024 - Chicago, IL

2024 ACG New York 16th Annual Healthcare Conference

June 26, 2024 - New York, NY

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

Industry M&A Activity

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A Transactions

Pharma & Biotech

13 transactions totaling $2,061 million


Supplies, Equipment & Services

14 transactions totaling $749 million


Healthcare Facilities & Distributors

2 transactions totaling $762 million


Healthcare IT & Managed Care

4 transactions totaling $21 million

Private Placements

Pharma & Biotech

35 transactions totaling $1,009 million


Supplies, Equipment & Services

13 transactions totaling $143 million


Healthcare Facilities & Distributors

3 transactions


Healthcare IT & Managed Care

6 transactions totaling $65 million

Public Offerings

Pharma & Biotech

24 transactions totaling $1,039 million


Supplies, Equipment & Services

10 transactions totaling $2,592 million


Healthcare Facilities & Distributors

3 transactions totaling $109 million


Healthcare IT & Managed Care

5 transactions totaling $2,262 million

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific subsectors.

Market Research

Insight Into Healthcare Related Industries

Bourne Brief: Navigating Tailwinds & Headwinds in Clinical Research Service

Bourne Partners - Nov 2023

Capital Markets Update: 2024 Outlook

Bourne Partners - Feb 2024

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product


Project Ignatius

Pharma Services | Sell-Side

Acquisition opportunity of Phase I clinical research site



Project Nirvana

Pharma | Capital Raise

Investment opportunity in sterile injectable pharmaceutical manufacturer and compounder

Project Panther

Pharma Services | Capital Raise

Investment opportunity in OTC and personal care CDMO


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

AstraZeneca snaps up Amolyt for $1.05bn to boost rare disease pipeline

Pharmaceutical Technology

Alcami Partners with Tanvex CDMO to Offer a Complete Solution for Biologics Developers

PR Newswire

Adare Pharma Solutions Expanding Oral Dose Capabilities In Europe

Adare Pharma Solutions

Ajinomoto Bio-Pharma Services Garners Six 'CDMO Leadership Awards,' Further Establishing Its Industry Excellence

PR Newswire

Charles River, Navega Therapeutics Enter Gene Therapy Mfg. Pact

Contract Pharma

Pace® Life Sciences Acquires New Jersey Laboratory from Curia

Pace Life Sciences

SMC Ltd. Expands Sterile Fill Finish Capabilities in North Carolina

Contract Pharma

Fortrea sells pair of businesses to private equity firm to become 'pure-play' CRO

Fierce Biotech

Noramco Forges Strategic Alignment with Purisys and Halo Pharma

Contract Pharma

The top 10 drugs losing US exclusivity in 2024

Fierce Pharma